ENDRA Life Sciences Retained Earnings (Accumulated Deficit) 2017-2024 | NDRA
ENDRA Life Sciences retained earnings (accumulated deficit) from 2017 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| ENDRA Life Sciences Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-103 |
| 2023 | $-92 |
| 2022 | $-82 |
| 2021 | $-69 |
| 2020 | $-57 |
| 2019 | $-45 |
| 2018 | $-28 |
| 2017 | $-18 |
| 2016 | $-13 |
| ENDRA Life Sciences Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-103 |
| 2024-09-30 | $-99 |
| 2024-06-30 | $-97 |
| 2024-03-31 | $-95 |
| 2023-12-31 | $-92 |
| 2023-09-30 | $-90 |
| 2023-06-30 | $-87 |
| 2023-03-31 | $-85 |
| 2022-12-31 | $-82 |
| 2022-09-30 | $-79 |
| 2022-06-30 | $-75 |
| 2022-03-31 | $-72 |
| 2021-12-31 | $-69 |
| 2021-09-30 | $-66 |
| 2021-06-30 | $-63 |
| 2021-03-31 | $-60 |
| 2020-12-31 | $-57 |
| 2020-09-30 | $-55 |
| 2020-06-30 | $-51 |
| 2020-03-31 | $-49 |
| 2019-12-31 | $-45 |
| 2019-09-30 | $-36 |
| 2019-06-30 | $-33 |
| 2019-03-31 | $-30 |
| 2018-12-31 | $-28 |
| 2018-09-30 | $-25 |
| 2018-06-30 | $-23 |
| 2018-03-31 | $-21 |
| 2017-12-31 | $-18 |
| 2017-09-30 | $-16 |
| 2017-06-30 | $-15 |
| 2017-03-31 | $-13 |
| 2016-12-31 | $-13 |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.004B | $0.000B |
| ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. | |||